Wednesday, March 23, 2011

Gilead prices $1 billion notes offering

Drug maker Gilead Sciences Inc. will sell $1 billion in senior unsecured notes, the company said Wednesday.
Gilead (NASDAQ: GILD), the Foster City-based leader in HIV drug treatments, expects to close the sale March 30. The notes will mature April 1, 2021, and bear interest at an annual rate of 4.5 percent.

No comments:

Post a Comment

Post a Comment